Pitfalls of testing and summary of guidance on safety monitoring with amiodarone and digoxin.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 17289735.
- Also identified by PMC identifier 1796674.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Patients on a range of drug therapies are often not monitored appropriately, even though this can improve patient safety. Knowledge of the effects of drugs on non-target body systems is essential to guide monitoring and interpretation of monitoring tests
Medical subject headings
- Amiodarone
- Anti-Arrhythmia Agents
- Atrial Fibrillation
- Digoxin